Siegfried is a leading contract development and manufacturing organization with a global network of 16 production sites across the US, Europe, China and Australia. With more than 150 years of experience, we are taking your innovations to industrial scale.
We offer CDMO services for small, midsize, and large pharmaceutical companies from preclinical to commercial, accelerating their time to market while ensuring quality and reliability.
Key capabilities include:
- Preclinical and early-phase development: The US-based Siegfried Acceleration Hub provides integrated development and manufacturing support, from phase-appropriate analytical development to scalable processes, accelerating the path from concept to clinic.
- Custom API manufacturing: Integrated process and analytical development, scale-up, GMP manufacturing and regulatory support for your custom API and HPAPI.
- Oral solid dosage forms: 30+ years of experience in complex OSD, including modified-release and highly potent products, from development through commercial manufacturing.
- Sterile injectables: End-to-end sterile and aseptic fill-finish for prefilled syringes, cartridges, vials and ampoules, from development and tech transfer to commercial supply.
- Ophthalmics: 95+ years of experience and a dedicated development center for complex ophthalmic formulations and processes.
- Inhalation: Filling of capsule-based dry powder inhalation products, including HPAPI handling, low-dose encapsulation and aerodynamic testing.
- Viral vectors: DINAMIQS, a Siegfried company, provides science-driven CDMO services for AAV and lentiviral vectors, supporting biotech and pharma companies in cell and gene therapy.